Associate Director, Billing Strategy - Denials & Appeals

About the role

Natera is seeking an Associate Director to lead the strategy, performance, and optimization of denied claims and appeals. This senior individual contributor role focuses on shaping denial management strategy, driving payer advocacy, and partnering cross-functionally to improve reimbursement outcomes. The role also involves supporting automation initiatives by translating operational expertise into system logic and collaborating with engineering and vendors.

Responsibilities

• Lead denial management and appeals strategy across all payer types.
• Define and track overturn rates, appeal timelines, and recovery performance.
• Act as an internal expert on payer policies and medical necessity criteria for laboratory testing.
• Partner with eligibility, prior authorization, coding, and billing teams to prevent denials.
• Audit BPO/vendor performance to identify workflow gaps and drive improvements.
• Translate denial and appeals workflows into system logic to support automation buildout.
• Define requirements for rules-based workflows, denial routing, and appeal triggers.
• Analyze datasets to quantify denial drivers and financial impact.

Required skills

• Revenue Cycle Management
• Denials and Appeals
• Laboratory billing
• CPT coding
• Payer policies
• Power BI
• SQL
• Excel
• Snowflake

Nice to have

• Automation initiatives
• Rules engines
• RPA
• Workflow automation
• AMD billing platform
• AI-driven workflows
• Jira

Qualifications

• 8–12+ years of experience in healthcare Revenue Cycle Management
• Expertise in laboratory billing, CPT coding, and reimbursement methodologies

Benefits

• Medical insurance
• Dental insurance
• Vision insurance
• Life insurance
• Disability plans
• Free testing
• Fertility care benefits
• Pregnancy and baby bonding leave
• 401k benefits
• Commuter benefits

About the Company

Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. The company aims to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions.